PSYENCE BIOMEDICAL LTD (PBM)

CA74449F1009 - Common Stock

0.3  -0.03 (-8.81%)

After market: 0.3 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

PSYENCE BIOMEDICAL LTD

NASDAQ:PBM (6/28/2024, 7:19:33 PM)

After market: 0.3 0 (0%)

0.3

-0.03 (-8.81%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorN/A
GICS IndustryN/A
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 MonthN/A
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap4.02M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

PBM Daily chart

Company Profile

Psyence Biomedical Ltd is a CA-based company operating in industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-12-10. Psyence Biomedical Ltd is a Canada-based company, which develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The firm has partnered with iNGENu Pty Ltd (iNGENu) to conduct the Company’s clinical trial in palliative care. iNGENu is an Australia-based, globally focused contract research organization (CRO) with experience working in the psychedelic pharmaceutical drug development and clinical research industry. Its Phase IIb clinical trial, using PEX010, a 25mg naturally derived psilocybin drug candidate product in-licensed by the Company, in the palliative care setting.

Company Info

PSYENCE BIOMEDICAL LTD

121 Richmond Street West Penthouse, Suite 1300

TORONTO ONTARIO V6E 3Z3

P: 17744604171

CEO: John Plourde

Employees: 0

Website: http://psyence.com

PBM News

ChartMill News Image6 days ago - ChartmillThese stocks have an unusual volume in today's session

On Monday, there are stocks with unusual volume. Let's take a look.

ChartMill News Image9 days ago - ChartmillWhat's going on in today's session

Friday's session: top gainers and losers

ChartMill News Image9 days ago - ChartmillOn Friday, there are stocks with unusual volume. Let's take a look.

Which stocks have an unusual volume on Friday?

ChartMill News Image9 days ago - ChartmillKeep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.

ChartMill News Image9 days ago - ChartmillTraders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.

The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

ChartMill News Image9 days ago - ChartmillCurious about the stocks that are showing activity before the opening bell on Friday?

As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

PBM Twits

Here you can normally see the latest stock twits on PBM, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example